Quantcast
Last updated on April 20, 2014 at 19:30 EDT

Latest Aliskiren Stories

2013-11-04 08:26:14

DENVER, Nov. 4, 2013 /PRNewswire/ -- Silvergate Pharmaceuticals, Inc., focused on the development and commercialization of innovative and safe medicines for children, today announced the availability by prescription of Epaned(TM) (enalapril maleate Powder for Oral Solution) to treat hypertension (high blood pressure) in people older than one month. Enalapril is one of the most commonly prescribed medicines in the United States to treat high blood pressure. (Logo:...

2013-09-12 16:26:45

Takeda and Arbor enter into a license, development and commercialization agreement for EDARBI (azilsartan medoxomil) and EDARBYCLOR (azilsartan medoxomil and chlorthalidone) in the U.S. DEERFIELD, Ill. and OSAKA, Japan and ATLANTA, Sept. 12, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) and Arbor Pharmaceuticals Ireland Ltd., a wholly-owned subsidiary of Arbor Pharmaceuticals, LLC ("Arbor") announced today that Takeda and Arbor have entered into a license, development...

2013-09-04 08:31:01

AQUARIUS trial data show Aliskiren reduced incidents of death, stroke, heart attack Patients with clogged and hardened arteries who already have their blood pressure under control may benefit from an additional blood pressure-lowering medication, according to research from the Cleveland Clinic Coordinating Center for Clinical Research (C5Research). The researchers found that the renin-inhibitor aliskiren tended to slow coronary disease progression and reduced the risk of death, stroke...

2013-08-14 16:25:21

Silvergate Pharmaceuticals Inc. Enables Consistent Dosing For Children DENVER, Aug. 14, 2013 /PRNewswire/ -- Silvergate Pharmaceuticals Inc, focused on the development and commercialization of innovative and safe medicines for children, today announced that the United States Food and Drug Administration (FDA) approved Epaned(TM) (enalapril maleate Powder for Oral Solution) to treat hypertension (high blood pressure) in people one month and older. Enalapril is one of the most commonly...

2013-04-18 23:19:17

d´Oliveira & Associates has issued a new infographic providing information on a Tekturna medical study that was stopped due to patients suffering from nonfatal stroke, hyperkalemia, and hypotension. (PRWEB) April 18, 2013 Tekturna (aliskiren), produced by Novartis, is a once-daily pill used to treat high blood pressure (hypertension) and is the first “Renin Inhibitor” drug that regulates the renin enzyme in the kidney. This process assists by narrowing the blood...

2012-11-05 15:04:16

Studies investigate the potential of several drugs for the treatment of patients with diabetes or kidney disease Three late-breaking studies presented during the American Society of Nephrology's Annual Kidney Week provide new information on drugs being tested in patients with diabetes or kidney disease. Hans-Henrik Parving, MD (University of Copenhagen, in Denmark) and his colleagues investigated whether the drug aliskiren might improve the prognosis of patients with type 2 diabetes who...

2012-09-11 22:25:52

Nearly 5 percent of pregnant women are prescribed drugs to treat high blood pressure, including some drugs that aren't considered safe for mothers or their babies, according to new research in the American Heart Association's journal Hypertension. Use of high blood pressure drugs during pregnancy is becoming increasingly common, said Brian T. Bateman, M.D., lead author and Assistant Professor of anesthesia at Harvard Medical School in Boston, Mass. "While we know high blood pressure, or...

2012-03-22 21:17:45

Drug manufacturer deviates from the appropriate comparator therapy specified by the G-BA The fixed drug combination of aliskiren and amlodipine (trade name: Rasilamlo®) was approved in April 2011 for the treatment of people with hypertension in whom aliskiren or amlodipine alone has an insufficient effect. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products” (AMNOG), the German Institute for Quality and Efficiency in Health Care...

2012-01-12 21:02:24

Researchers at St. Michael's Hospital have published the first detailed figures showing the risk of using the prescription drug Rasilez in combination with certain other blood pressure-lowering medications. The pharmaceutical company Novartis terminated a large, international clinical trial of the drug last month after finding an increased incidence after 18-24 months of non-fatal strokes, renal complications, high levels of potassium in the blood and low blood pressure. As a result,...

High Blood Pressure Can Raise Risk Of Birth Defects
2011-10-19 07:45:46

Women with high blood pressure (hypertension) during early pregnancy are more likely to have babies born with major birth defects, regardless of their use of prescribed medications to control the condition, according to new research published in the online edition of the British Medical Journal on Oct. 18. Pregnant women have been warned for years to avoid angiotensin-converting enzyme (ACE) inhibitors during the later stages of pregnancy to avoid the possibility of birth defects. But...